How many brands share Thermage’s AAA Well-Known Trademark status in China?

Thermage is one of only 217 brands across mainland China to receive AAA status. According to Bausch Health, this limited group reflects top-tier brands recognized for exceptional reputation, consumer confidence, and market influence within China’s domestic trademark evaluation system.

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Bausch Health (NYSE:BHC) and its aesthetic business Solta Medical announced that flagship brand Thermage® received the prestigious AAA Well-Known Trademark Certification from the China Trademark Association.

This top-tier recognition, held by only 217 brands in mainland China, highlights Thermage's brand reputation, consumer confidence, and market influence built over more than a decade in China.

AI-generated analysis. How Rhea-AI works. Not financial advice.

News Market Reaction – BHC

-0.92%

-0.92% News Effect

On the day this news was published, BHC declined 0.92%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights a branding milestone for Bausch Health’s Thermage® platform, with AAA W...

Analysis

This announcement highlights a branding milestone for Bausch Health’s Thermage® platform, with AAA Well-Known Trademark Certification in China and over 5 million treatments performed worldwide. In recent months, Bausch Health reported growing Q1 2026 revenue of $2.52 billion and higher adjusted profitability, alongside additional dermatology launches. Investors may focus on how such recognition supports longer-term aesthetic franchise momentum within the broader portfolio and complements the company’s existing earnings trajectory.

Key Figures

Thermage treatments: over 5 million treatments Q1 2026 revenue: $2.52 billion GAAP net loss: $1,423 million +5 more

8 metrics

Thermage treatments over 5 million treatments Cumulative worldwide usage mentioned in Thermage® branding news

Q1 2026 revenue $2.52 billion Q1 2026 results; up 12% reported, 7% organic

GAAP net loss $1,423 million Q1 2026, driven by goodwill impairment

Goodwill impairment $1,426 million Q1 2026 non-cash charge impacting GAAP results

Adjusted EPS $0.78 Q1 2026, up 32% year over year

Adjusted EBITDA $837 million Q1 2026, up 27% year over year

Consolidated cash $1.299 billion Cash balance as of March 31, 2026

Market cap $2,013,033,721 Pre-news equity value based on latest price

Historical Context

5 past events · Latest: May 19 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 19	Annual meeting results	Neutral	+2.0%	Shareholders elected 10 directors and approved routine governance items.
May 13	Conference participation	Neutral	-2.2%	Management scheduled for fireside chat at RBC healthcare conference.
May 12	Conference participation	Neutral	-2.2%	Company announced appearance at Barclays leveraged finance conference.
Apr 29	Quarterly earnings	Positive	+2.3%	Q1 2026 revenue grew with higher adjusted EPS/EBITDA and guidance reaffirmed.
Apr 14	Dermatology launch	Positive	-0.7%	Launch of Biafine® skin emulsion in U.S. via online channels.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has generally aligned with price moves, with one instance where a positive product launch coincided with a modest decline.

Recent Company History

Over the past months, Bausch Health reported Q1 2026 revenue of $2.52 billion with higher adjusted EPS and EBITDA and reaffirmed 2026 guidance, which was followed by a 2.33% gain. Routine governance and conference participation around May 12–20, 2026 produced modest, mixed moves. A dermatology product launch on April 14, 2026 saw a slight decline. Today’s China trademark recognition for Thermage® adds another brand-focused milestone alongside prior dermatology expansion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/28/2026 - 04:15 PM

Thermage^®, a pioneer in non-invasive skin tightening, was awarded the AAA Well-Known Trademark Certification, the highest recognition in China's domestic trademark evaluation system.

LAVAL, QC, May 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, are proud to announce that their flagship brand, Thermage^®, was awarded the prestigious AAA Well-Known Trademark Certification ("AAA") by the China Trademark Association (CTA), a renowned accreditation reserved for top-tier brands. This elite distinction—earned by only 217 brands across mainland China—recognizes Thermage's exceptional brand reputation, consumer confidence, and market influence.

"Joining an elite group of only 217 brands nationwide, this distinction cements Thermage's position as a leader in medical aesthetics and is a powerful validation of the reliability and confidence we have established with consumers and practitioners in China," said Thomas J. Appio, CEO of Bausch Health. "It underscores our commitment to innovation with the highest standards of quality and safety."

"With over a decade of presence in China, and over 5 million treatments performed worldwide, Thermage^® has earned its reputation as a leader in non‑invasive aesthetic treatments," said Jiny Kim, Senior Vice President, Solta Medical, Bausch Health. "The AAA rating serves as a credible "mark of trust," allowing consumers to choose Thermage^® with confidence in its legitimacy and product integrity."

About Thermage^® FLX system

INDICATIONS

The radiofrequency energy only delivery components of the Thermage^® FLX system and accessories are indicated for use in:
- Dermatologic and general surgical procedures for electrocoagulation and hemostasis
- Non-invasive treatment of wrinkles around the eyes, including upper and lower eyelids
- Non-invasive treatment of wrinkles
The simultaneous application of radiofrequency energy and skin vibration by the Thermage^® FLX system and accessories are indicated for use in:
- Dermatologic and general surgical procedures for electrocoagulation and hemostasis
- Non-invasive treatment of wrinkles around the eye
- Non-invasive treatment of wrinkles
- Temporary improvement in the appearance of cellulite
- Relief of minor muscle aches and pain
- Relief of muscle spasms
- Temporary improvement of local circulation (blood circulation)

IMPORTANT SAFETY INFORMATION

Do not undergo Thermage^® treatment if you have a cardiac pacemaker, a cardioverter, a defibrillator, or any other electrical implant. Let your doctor know if you have an electrical implant or if you have any questions about whether you should undergo a Thermage^® treatment.
Solta Medical has not studied the use of the Thermage^® system:
- Over skin fillers (lips, cheeks, facial wrinkles and skin folds)
- In people who are pregnant and/or breast feeding, diabetic, have an auto-immune disease such as lupus, have cold sores, have genital herpes, or have epilepsy
- In people who have permanent make-up and/or tattoos
- In children

The most commonly reported adverse effect during treatment is mild to moderate pain in the area being treated.
- The most commonly reported adverse effects after treatment include the following:
- Mild redness may occur and typically resolves within 24 hours.
- Swelling may occur and typically resolves within 5 days but can remain up to several weeks.
- The following adverse effects occur infrequently:
  - The procedure may produce heating in the upper layers of the skin, causing burns and subsequent blister and scab formation. There is a possibility of scar formation.
  - Skin surface irregularities may appear up to 1 or more months post-treatment.
  - Numbness, tingling" or temporary paralysis may occur; typically resolves in a short period of time but may persist up to several weeks.
  - Lumps or nodules may occur under the skin primarily in the neck area, and usually resolve within 1 or 2 weeks without chronic or long-term complications.
  - Skin may darken, but normally resolves within several months.

Talk to your doctor for more information about Thermage^® and see thermage.com for additional details.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. Our aesthetic business, Solta Medical, is a global leader in the aesthetics market, whose vision is to develop and support trusted aesthetic brands that provide value to our customers and patients. More information about Solta Medical can be found at www.solta.com. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:	Media Contact:
Garen Sarafian	Katie Savastano
ir@bauschhealth.com	corporate.communications@bauschhealth.com
(877) 281-6642 (toll free)	(908) 569-3692

BHC-PRODUCTS

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-healths-aesthetic-business-solta-medical-earns-prestigious-trademark-certification-of-thermage-in-china-302784868.html

SOURCE Bausch Health Companies Inc.

FAQ

What AAA Well-Known Trademark Certification did Thermage receive in China for BHC?

Thermage received the AAA Well-Known Trademark Certification, the highest recognition in China’s domestic trademark evaluation system. According to Bausch Health, this prestigious status from the China Trademark Association is reserved for top-tier brands and underscores Thermage’s strong brand reputation and market influence.

Why is the Thermage AAA trademark certification important for Bausch Health (NYSE:BHC) investors?

The AAA certification signals strong brand recognition and trust for Thermage in China. According to Bausch Health, joining only 217 elite brands nationwide reflects Thermage’s consumer confidence, market influence, and leadership in medical aesthetics, which can support long-term positioning in a key aesthetics market.

What does the AAA rating mean for Thermage’s credibility in the Chinese aesthetics market?

The AAA rating serves as a strong mark of trust for Thermage in China. According to Bausch Health, it helps consumers choose Thermage with confidence in the brand’s legitimacy, product integrity, and established reputation in non-invasive aesthetic treatments.

How long has Thermage operated in China and how many treatments have been performed worldwide?

Thermage has been present in China for over a decade and has surpassed 5 million treatments worldwide. According to Bausch Health, this long-term presence and treatment volume support Thermage’s reputation as a leader in non-invasive aesthetic procedures.

How does the AAA certification support Thermage’s position in medical aesthetics for BHC?

The AAA certification reinforces Thermage’s role as a leader in medical aesthetics, especially in China. According to Bausch Health, the recognition validates reliability, quality, and safety standards that underpin consumer and practitioner confidence in Thermage non-invasive skin tightening treatments.